Literature DB >> 21273140

Effect of bariatric surgery on normal and abnormal renal function.

D P Schuster1, M Teodorescu, D Mikami, K Foreman, P Rogers, B J Needleman.   

Abstract

BACKGROUND: Obesity has been associated with hypertension, diabetes mellitus, and metabolic syndrome, risk factors for chronic kidney disease. In addition, obesity has been found to have an independent, negative effect on renal function and the progression of renal insufficiency.
METHODS: The serum creatinine (CR) in 813 patients who had undergone obesity surgery from 2003 to 2009 at a large academic medical center and had been followed up for ≥24 months was retrospectively monitored. Renal function, as measured by the CR level, was assessed at baseline and at 6, 12, and ≥24 months of follow-up. The groups were stratified by the baseline CR as follows: normal (CR <1.3 mg/dL), mild impairment (CR 1.3-1.6 mg/dL), and moderate impairment (CR >1.6 mg/dL).
RESULTS: Of the 813 patients, 757 had a CR <1.3 mg/dL at baseline. Of those 757 patients, 97.6% had maintained a CR of <1.3 mg/dL, 1.3% had a CR of 1.3-1.6 mg/dL, 1.1% had a CR of >1.6 mg/dL (n = 757) at 6 months of follow-up. At 1 year of follow-up, 99% had maintained a CR of <1.3 mg/dL and 1% had a CR of >1.3% (n = 509). At 2 years of follow-up, 100% had a CR value of <1.3 mg/dL (n = 388). Of the remaining 56 patients, 71.4% had been classified as having mild impairment (CR 1.3-1.6 mg/dL) and 28.5% as having moderate impairment (CR >1.6 mg/dL) before weight loss surgery. Examination of the CR values at ≥2 years after weight loss surgery demonstrated that 76.7% had a normal CR level, 12.5% had mild impairment, and 10.7% had moderate impairment.
CONCLUSION: Bariatric surgery does not have a negative effect on renal function as measured by the CR, whether CR at baseline is <1.3 or ≥1.3 mg/dL when monitored for ≥24 months. For those with impaired renal function and a CR ≥1.3 mg/dL, improvement in CR was seen in 76.7% at ≥2 years postoperatively, at a point at which the weight loss velocity, hydration, and nutritional status have stabilized. The weight loss associated with bariatric surgery could potentially have a positive effect on renal function at ≥24 months, such as was found in the present study by a stable or reduced CR level. The etiology for this might be a direct effect of weight loss on impaired renal function or an indirect effect by reducing the rates of co-morbidities, such as diabetes mellitus and hypertension, both risk factors for renal disease. Additional prospective studies, including weight-matched controls, are needed.
Copyright © 2011 American Society for Metabolic and Bariatric Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21273140     DOI: 10.1016/j.soard.2010.11.015

Source DB:  PubMed          Journal:  Surg Obes Relat Dis        ISSN: 1550-7289            Impact factor:   4.734


  15 in total

1.  Changes in renal function following Roux-en-Y gastric bypass: a prospective study.

Authors:  Jorge L Zelada Getty; Isam N Hamdallah; Hazem N Shamseddeen; Jennifer Wu; Roger K Low; Jacqueline Craig; Mohamed R Ali
Journal:  Obes Surg       Date:  2012-07       Impact factor: 4.129

Review 2.  [Diabetic kidney disease - Update 2016].

Authors:  Harald Sourij; Roland Edlinger; Friedrich Prischl; Martin Auinger; Alexandra Kautzky-Willer; Marcus D Säemann; Rudolf Prager; Martin Clodi; Guntram Schernthaner; Gert Mayer; Rainer Oberbauer; Alexander R Rosenkranz
Journal:  Wien Klin Wochenschr       Date:  2016-04       Impact factor: 1.704

3.  Bariatric Surgery Is Protective Against Renal Function Decline in Severely Obese Patients in the Long-Term.

Authors:  Anne Lautenbach; Jan-Wilhelm Wienecke; Fabian Stoll; Nina Riedel; Oliver Mann; Tobias B Huber; Philipp Busch; Jens Aberle
Journal:  Obes Surg       Date:  2020-11-07       Impact factor: 4.129

Review 4.  Clinical Outcomes of Metabolic Surgery: Microvascular and Macrovascular Complications.

Authors:  Ted D Adams; David E Arterburn; David M Nathan; Robert H Eckel
Journal:  Diabetes Care       Date:  2016-06       Impact factor: 19.112

5.  Clinical and Metabolic Effects of Biliopancreatic Diversion Persist After Reduction of the Gastric Pouch and Elongation of the Common Alimentary Tract. Preliminary Report in a Series of Patients with a 10-Year Follow-Up.

Authors:  Valerio Ceriani; Francesco Cetta; Tiziana Lodi; Ferdinando Pinna; Antonio E Pontiroli
Journal:  Obes Surg       Date:  2017-06       Impact factor: 4.129

6.  Improvement of Renal Function After Bariatric Surgery: a Systematic Review and Meta-analysis.

Authors:  Hongyan Huang; Jun Lu; Xiaojiang Dai; Zhixin Li; Liyong Zhu; Shaihong Zhu; Liangping Wu
Journal:  Obes Surg       Date:  2021-08-06       Impact factor: 4.129

Review 7.  Obesity in kidney disease: A heavyweight opponent.

Authors:  Raphael Jose Ferreira Felizardo; Marina Burgos da Silva; Cristhiane Favero Aguiar; Niels Olsen Saraiva Câmara
Journal:  World J Nephrol       Date:  2014-08-06

8.  Kidney outcomes three years after bariatric surgery in severely obese adolescents.

Authors:  Edward J Nehus; Jane C Khoury; Thomas H Inge; Nianzhou Xiao; Todd M Jenkins; Marva M Moxey-Mims; Mark M Mitsnefes
Journal:  Kidney Int       Date:  2016-12-01       Impact factor: 10.612

9.  The effect of biliopancreatic diversion surgery on renal function--a retrospective study.

Authors:  Biju Jose; Stephen Ford; Paul Super; G Neil Thomas; Indranil Dasgupta; Shahrad Taheri
Journal:  Obes Surg       Date:  2013-05       Impact factor: 4.129

Review 10.  Is Bariatric Surgery an Effective Treatment for Type II Diabetic Kidney Disease?

Authors:  Allon N Friedman; Bruce Wolfe
Journal:  Clin J Am Soc Nephrol       Date:  2015-10-08       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.